PanMETAI combines AI and NMR metabolomics to detect early-stage pancreatic cancer from a blood sample, achieving 93 percent ...

More than half of transplant recipients in a large analysis developed chronic graft-versus-host disease, and 15% died from causes other than cancer relapse. Those numbers capture the uneasy truth of ...

Learn the distinctions between simple and stratified random sampling. Understand how researchers use these methods to accurately represent data populations.

Scientists at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have developed a new way to determine atomic structures from nanocrystals previously considered unusable, ...

Discover strategies to overcome sample preparation challenges in clinical proteomics, optimizing workflows for researchers.

Protein S deficiency represents a rare but significant hereditary thrombophilia that poses substantial risks during pregnancy ...

This study reclassified patients according to modern WHO Classification criteria by integrating multi-dimensional molecular markers. It thoroughly investigated the clinical and molecular disparities ...

Introduction: Obstetric referrals remain a public health challenge. Objective: To evaluate the prevalence of obstetric referrals in the DASSA-Glazoué health district. M ...

A proteomics data pipeline transforms raw mass spectrometry spectra into biologically interpretable protein-level ...

Recent advancements in systems biology have been propelled by the increasing power of omics technologies—spanning genomics, transcriptomics, proteomics, ...

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AßOs) for the treatment of Alzheimer ...

Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...